Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001171843-21-001062
Filing Date
2021-02-16
Accepted
2021-02-16 16:35:16
Documents
2
Group Members
2004597 ONTARIO INC.2004598 ONTARIO INC.2526386 ONTARIO INC.DAMIAN LAMBGENESYS CAPITAL MANAGEMENT (FUND III) INC.GENESYS CAPITAL MANAGEMENT INC.GENESYS GENERAL PARTNER (FUND III) INC.GENESYS GENERAL PARTNER (FUND III) LPGENESYS GENERAL PARTNER INC.GENESYS

Document Format Files

Seq Description Document Type Size
1 FORM SC 13G/A sc13ga_021221.htm SC 13G/A 218409
2 EXHIBIT 1 exh_1.htm EX-1 16823
  Complete submission text file 0001171843-21-001062.txt   237451
Mailing Address 2400 SKYMARK AVENUE, UNIT 6 MISSISSAUGA A6 L4W 5K5
Business Address 2400 SKYMARK AVENUE, UNIT 6 MISSISSAUGA A6 L4W 5K5 647-476-1350
Profound Medical Corp. (Subject) CIK: 0001628808 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91344 | Film No.: 21639500
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 123 FRONT STREET WEST SUITE 1503 PO BOX 34 TORONTO A6 M5J 2M2
Business Address 123 FRONT STREET WEST SUITE 1503 PO BOX 34 TORONTO A6 M5J 2M2 (416) 598-4900
Genesys Ventures II LP (Filed by) CIK: 0001806939 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G/A